Clinical Trials Browser

Has results × sulindac sulfone × Genitourinary × Clear all

NCT00283803 2018-08-07

Exisulind and Intermittent Androgen Suppression (ADT) in Biochemical Relapsed Prostate Cancer

Phase 2 Completed

32 enrolled 9 charts

Prostatic Neoplasms